Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the proposed Innovative Medicines Fund on personalised cancer treatments.

NHS England and NHS Improvement and the National Institute for Health and Care Excellence are currently developing proposals for the Innovative Medicines Fund (IMF) and expect to lead a public engagement exercise later this year. The IMF will build on and extend the successful Cancer Drugs Fund which has provided access to the most promising cancer medicines to over 64,000 National Health Service patients. The IMF will continue to support patient access to personalised cancer medicines where appropriate.